Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Early Initiation of SGLT2 Inhibitors in Acute Heart Failure: a Focus on Diuresis and Renal Protection ; day:13 ; month:10 ; year:2023 ; pages:1-4
Cardiovascular drugs and therapy ; (13.10.2023), 1-4
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10557-023-07512-6
- URN
-
urn:nbn:de:101:1-2024010308365044196923
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hammer, Andreas
- Niessner, Alexander
- Sulzgruber, Patrick
- SpringerLink (Online service)
Ähnliche Objekte (12)
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin
Neuroimmune system-mediated renal protection mechanisms
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin
Neuroimmune system-mediated renal protection mechanisms
Renal Protection with SGLT2 Inhibitors: Effects in Acute and Chronic Kidney Disease
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors
Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2
SGLT2 Inhibitors – The New Standard of Care for Cardiovascular, Renal and Metabolic Protection in Type 2 Diabetes: A Narrative Review
Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms
Erythropoietin and renal protection
Management of Hyperuricemia in Patients with Chronic Kidney Disease: a Focus on Renal Protection
SGLT2 and cancer
The Na/K-ATPase Signaling and SGLT2 Inhibitor-Mediated Cardiorenal Protection: A Crossed Road?
Use of SGLT2 Inhibitors in Diabetic Renal Transplant Recipients: A Mixed Method Exploratory Exercise
Repurposing SGLT2 inhibitors: treatment of renal proximal tubulopathy in Fanconi‐Bickel syndrome with empagliflozin